跳至主要内容
临床试验/NCT03090399
NCT03090399已完成不适用

Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery

Fondazione Policlinico Universitario Agostino Gemelli IRCCS0 个研究点目标入组 60 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
主要终点
prevalence of complications

研究概览

简要总结

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • cardiac diseases
  • pulmonary diseases
  • renal diseases
  • metabolic disorders

结局指标

主要结局

prevalence of complications

时间窗: up to 30 days

次要结局

  • days of hospitalization(up to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.Andrea Russo

Medical Doctor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

相似试验